Combined therapy of tofacitinib plus iguratimod improves rheumatoid arthritis-usual interstitial pneumonia
According to a recent study published in Frontiers in Immunology, the combination of tofacitinib and iguratimod is superior to conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs) …